Freshfields-Led AstraZeneca To Buy Vaccine Maker For $1.1B
Anglo-Swedish pharmaceutical giant AstraZeneca said Tuesday that it will buy Icosavax, a U.S. biopharmaceutical company, for up to $1.1 billion to add a vaccine for life-threatening respiratory diseases to its arsenal...To view the full article, register now.
Already a subscriber? Click here to view full article